Arkolith/Insider Trading/GSTC/Form 4/A

Katzaroff James C

CEO, DirectorGlobeStar Therapeutics Corp (GSTC) · full profile →Form 4/A · filed Apr 4, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
1 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 3, 2023Other(J)7.0M$0.01$70K17.0M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 24, 2023Grant(A)35.0M—$065.0M
May 12, 2021Grant(A)30.0M—$030.0M

Transaction Codes

J
Other acquisition / disposition
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4/A filing (accession 0001161697-23-000225) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4/A XML